中文

Faculty

Min Liu

Min Liu

Min Liu

  • Professor
  • liumin@bjmu.edu.cn
  • Xueyuan Road 38, Haidian District, Beijing, China
  • Peking University
Personal profile

Prof. Liu is a professor of epidemiology and biostatistics at the School of Public Health, Peking University. She is also the Deputy Director in the Center for HIV/AIDS Prevention Research Center in Peking University. Her research interests focus on three broad topics: (1) epidemiology of infectious diseases; (2) reproductive health; and (3) Big data research and application in health. Prof. Liu is the chairman of the vice president of the second national council of maternal and child health research association, vice president of the community health promotion association in Beijing, chairman of big data working committee of on rehabilitation in the rehabilitation medical association of China, member of Expert panel of China National Health Commission, etc.. As a principal investigator, she has completed more than 50 national projects, which were funded by the National Natural Science Foundation, the Ministry of Science and Technology, the National Health Commission of China, etc. She has published more than 270 papers, including Lancet global health (IF 26.763)Lancet infectious disease (IF 25.071)Gut (IF 23.059)Bull World Health Organ (IF 9.408), etc. She has awarded the first prize of the Beijing Science and Technology Award, the first prize of the Science and Technology Award of the Chinese Preventive Medicine Association, the first prize of National Maternal and Child Health Science and Technology Award, Advanced Collective for National Science and Technology System to Combat COVID-19 (Leader), etc..



Main research directions

1. Epidemiology of infectious diseases

2. Reproductive health

3. Big data research and application in health



Representative scientific research projects

 1. Research on Public Health Risk Prevention and Model Innovation under the Background of "One Belt and One Road", supported by the National Natural Science Foundation of China (2020-2024)

2. Research and application of an intelligent active surveillance and early warning system for global major emergent infectious diseases, supported by the National Key R&D Program of China (2021, Dec-2024, Nov)

3. Study on Evaluation of Epidemiology and Prevention and Control Strategy of New Coronavirus Transmission, supported by the National Key Research and Development Project of China (2020, April-2020, Dec)

4. Big data-driven empirical research on integrated strategies for hepatitis B prevention and control by taking family as a unit, supported by the National Natural Science Foundation of China (2019-2022)

5. Research on COVID-19 emergency management guarantee strategy, supported by the Capital Health Development Research Project (2021, June-2021, Dec)

6. Study on financial burden of people living with HIV in accessing health care services and the strategies to address the catastrophic costs due to HIV in China, supported by the WHO (2020, Aug-2021, May)

7. Multi-Disciplinary Study on Poverty, Vulnerability and HIV with an Emphasis on Women Living with HIV (WLHIV), supported by the UN women (2020, Oct-2020, Dec)

8. Study of the epidemiology, assessment and prediction model on HIV/AIDS in China, supported by the National Major Scientific and Technological Special Project of China (2012-2015)

9. Study on early warning index system of sub-health state and development of early warning model, supported by the National 11th "Five-Year" Science and Technology Support Program of China (2008-2013)

10. Study on appropriate techniques for early identification and early warning of fever and diarrhea in community, supported by the National High Technology Research and Development Program of China (2008-2012)



10 representative papers

 1 Liu J*, Zhang S*, Liu M#, Wang Q, Shen H, Zhang Y. Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study. Lancet Glob Health. 2017;5(6):e624-e632. (IF=26.763)

2. Liu J*, Zhang S*, Wang Q, Shen H, Zhang M, Zhang Y, Yan D, Liu M#. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study. Lancet Infect Dis. 2016;16(1):80-6. (IF= 25.071)

3. Liu M#, Zhang S, Liu J, Wang Q, Shen H. Changing hepatitis B virus epidemiology in rural China. Lancet Infect Dis. 2016;16(2):151-2. (IF= 25.071)

4. Liu J*, Tao L*, Liu X, Yao H, Yu S, Wang Q, Zhang J, Gao Z, Jiang R, Jing W, Liu M#. GI symptoms and fever increase the risk of severe illness and death in patients with COVID-19. Gut. 2021;70(2):442-4. (IF=23.059)

5. Liu J, Liang W, Jing W, Liu M#. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019. Bull World Health Organ 2019;97:230-8. (IF=9.408)

6. Liu Q*, Jing W*, Kang L, Liu J#, Liu M#. Trends of the global, regional and national incidence of malaria in 204 countries from 1990 to 2019 and implications for malaria prevention. J Travel Med. 2021;28(5):taab046. (IF=8.490)

7. Ma Q*, Liu J*, Liu Q, Kang L, Liu R, Jing W, Wu Y, Liu M#. Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021 Dec 1;4(12):e2137257. (IF=8.483)

8. Wu Y*, Jing W*, Liu J, Ma Q, Yuan J, Wang Y, Du M, Liu M#. Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries. Sci Total Environ. 2020;729:139051. (IF=7.963)

9. Yuan J, Wu Y, Jing W, Liu J, Du M, Wang Y, Liu M#. Association between meteorological factors and daily new cases of COVID-19 in 188 countries: A time series analysis. Sci Total Environ. 2021;780:146538. (IF=7.963)

10. Yuan J*, Wu Y*, Jing W, Liu J, Du M, Wang Y, Liu M#. Non-linear correlation between daily new cases of COVID-19 and meteorological factors in 127 countries. Environ Res. 2021;193:110521. (IF=6.498)